Kintara Therapeutics Inc. sell bundfuture
Start price
01.12.22
/
50%
€8.82
Target price
01.12.23
-
Performance (%)
57.03%
End price
10.12.22
€13.85
Summary
This prediction ended on 10.12.22 with a price of €13.85. The price for Kintara Therapeutics Inc. massively increased, which is bad news for the SELL prediction by bundfuture. bundfuture has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kintara Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % | 49,79 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % | 88,25 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % | 61,92 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % | 63,54 % |
According to bundfuture what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by bundfuture for this prediction
In the thread Kintara Therapeutics Inc. diskutieren
Sell Kintara Therapeutics Inc.